In conjunction with RACI100
56 days till the Conference | Contact us

Program - Thursday 27 July

8:30 Congress PlenaryProfessor Oliver Einsle, Spemann Graduate School of Biology and Medicine Freiburg
9:35 Session 1
STRUCTURE-BASED PRECISION DESIGN: DISCOVERY OF POTENT AND SELECTIVE INHIBITORS OF CDC2-LIKE KINASE 1 AS AUTOPHAGY INDUCERSSheng-Yong Wang
10:10 IMPROVING THE CORRELATION BETWEEN PREDICTED AND DETERMINED BIOACTIVITIES USING QUANTUM MECHANICS CHARGE FOR DRUG DESIGNWeiliang Zhu
10:30 KNOWLEDGE BASED MASS SPECTROSCOPIC NATURAL PRODUCT RESEARCH PLATFORM, FLORA GENESIS SYSTEMTai No
10:50 Morning tea 25 Mins
11:15 Session 2
THERAPEUTIC STRATEGIES FOR TREATMENT OF FLT3-ITD+ AML - FROM DRUG DISCOVERY TO PRECISE CLINICAL APPLICATION: OPPORTUNITIES, CHALLENGES AND SOLUTIONSQingsong Liu
11:50 ENZYME KINETICS-DRIVEN” DESIGN, AND SYNTHESIS OF DC511020, ONE NICE CLINICAL CANDIDATE FOR ANTI-ALLZHEIMER’S DISEASE(AD) TREATMENTHong Liu
12:10 VIRTUAL SCREENING APPROACHES FOR IDENTIFICATION OF NOVEL SCAFFOLDS FOR CYPD AND SETDB1/ESET INHIBITORS AS POTENTIAL TREATMENTS FOR NEURODEGENERATIVE DISEASESAi Pae
12:30 COMPUTER-AIDED DESIGN OF INHIBITORS TARGETING HUMAN SIALYLTRANSFERASESAndrew Montgomery
12:45 NATURAL PRODUCTS USED AS CHEMICAL LIBRARY FOR PROTEIN-PROTEIN INTERACTIONS (PPIS) TARGETED DRUG DISCOVERYXuemei Jin
13:00 Lunch 60 Mins
14:00 Session 3
CHALLENGES IN MOLECULAR SIMILARITY SEARCHINGNaomie Binti Salim
14:35 REVISITING THE INTER-RELATIONSHIP BETWEEN CORRELATION COEFFICIENT, SAMPLE SIZE, AND CONFIDENCE LEVELRenxiao Wang
14:55 MAPPING OF DRUG-LIKE CHEMICAL UNIVERSE WITH REDUCED COMPLEXITY MOLECULAR FRAMEWORKSAleksejs Kontijevskis
15:15 DISCOVERING BINDING PATHWAYS AND METASTABLE STATES WITH MARKOV STATE MODELSTrayder Thomas
15:30 Coffee Break 25 Mins
15:55 Session 4
LESS IS MORE: DISTILLING HUMAN-INTERPRETABLE SIMPLICITY FROM MODELS OF LARGE QHTS RESULT MATRICESJB Browne
16:25 METHOD DEVELOPMENT FOR PREDICTION OF DRUG-TARGET INTERACTIONS Yun Tang
16:40 PREMETABO FOR PREDICTION OF DRUG METABOLISM IN HEPATOCYTES: PHASE I, PHASE II, AND TRANSPORTERSHyun Kil Shin
17:00 Congress PlenaryDr Alexander Makarov, Thermo Fisher Scientific Bremen